← 返回

对“细胞表面 GRP78 导向的 CAR-T 细胞在临床前模型中可有效治疗人胰腺癌”的勘误 [Translational Oncology volume 39 (2024) 101803]

英文原题:Corrigendum to "Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models" [Translational Oncology volume 39 (2024) 101803].

查看英文原题

Corrigendum to "Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models" [Translational Oncology volume 39 (2024) 101803].

PubMed 2024/12/27(内容时间) Transl Oncol Q2 · IF 4.9(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

摘要

这条来源本身就没有摘要(PubMed 未提供),不是「还没翻译」。可以点最下面的「在 PubMed 查看」打开原文献页面。

论文信息

作者
Yuan Y、Fan J、Liang D、Wang S、Luo X、Zhu Y、Liu N、Xiang T
第一作者单位
Laboratory of Animal Tumor Models, Frontiers Science Center for Disease-Related Molecular Network, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.China
通讯作者单位
Laboratory of Animal Tumor Models, Frontiers Science Center for Disease-Related Molecular Network, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China. Electronic address: zhaoxudong@wchscu.cn.China
文献类型
勘误
期刊
Translational oncology2025 Feb
原文标识
PubMed 39848760 · DOI 10.1016/j.tranon.2024.102252